ADMA Biologics Inc banner

ADMA Biologics Inc
NASDAQ:ADMA

Watchlist Manager
ADMA Biologics Inc Logo
ADMA Biologics Inc
NASDAQ:ADMA
Watchlist
Price: 16.36 USD 4.94%
Market Cap: $3.9B

Balance Sheet

Balance Sheet Decomposition
ADMA Biologics Inc

Balance Sheet
ADMA Biologics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
0
0
13
26
17
10
10
43
23
27
56
51
87
51
103
Cash Equivalents
0
0
13
26
17
10
10
43
23
27
56
51
87
51
103
Short-Term Investments
0
0
0
3
5
6
5
0
0
0
0
0
0
0
0
Total Receivables
0
0
0
0
0
1
1
4
1
4
13
29
16
27
50
Accounts Receivables
0
0
0
0
0
1
1
4
1
4
13
29
16
27
50
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
3
1
1
2
2
3
5
13
19
53
82
125
163
173
170
Other Current Assets
0
0
0
0
0
0
0
3
2
3
3
4
5
5
8
Total Current Assets
4
1
14
31
24
21
22
62
45
86
154
209
270
257
331
PP&E Net
1
1
1
1
3
2
2
31
30
33
46
58
69
63
63
PP&E Gross
1
1
1
1
0
2
2
31
30
33
46
58
69
63
63
Accumulated Depreciation
1
1
1
1
0
2
2
1
3
6
9
13
20
27
34
Intangible Assets
0
0
0
0
0
0
0
5
4
3
2
2
1
0
0
Goodwill
0
0
0
0
0
0
0
4
4
4
4
4
4
4
4
Long-Term Investments
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
7
7
1
2
4
5
5
90
Other Assets
0
0
0
0
0
0
0
4
4
4
4
4
4
4
4
Total Assets
5
N/A
3
-44%
16
+438%
32
+105%
27
-16%
24
-12%
24
N/A
108
+356%
89
-18%
127
+43%
208
+63%
276
+33%
349
+26%
329
-6%
489
+48%
Liabilities
Accounts Payable
1
1
1
3
2
2
3
6
6
9
11
12
13
16
20
Accrued Liabilities
1
1
1
1
2
2
2
3
4
5
9
17
24
31
30
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
7
1
0
0
0
0
6
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
1
2
3
5
Total Current Liabilities
9
2
2
4
4
4
11
9
10
14
20
30
39
50
56
Long-Term Debt
0
0
4
5
15
16
14
43
44
83
93
95
143
131
72
Other Liabilities
0
0
0
2
2
3
3
15
15
4
7
10
14
14
12
Total Liabilities
9
N/A
3
-73%
6
+144%
10
+70%
21
+102%
23
+9%
28
+23%
68
+141%
69
+2%
101
+46%
119
+18%
135
+13%
197
+45%
194
-1%
140
-28%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
24
30
37
53
69
87
107
151
216
265
341
412
478
506
309
Additional Paid In Capital
20
30
47
74
76
88
103
191
236
291
429
553
630
641
658
Total Equity
4
N/A
0
N/A
9
+2 250%
22
+130%
6
-72%
1
-87%
5
N/A
40
N/A
20
-51%
26
+32%
88
+237%
141
+60%
152
+8%
135
-11%
349
+158%
Total Liabilities & Equity
5
N/A
3
-44%
16
+438%
32
+105%
27
-16%
24
-12%
24
N/A
108
+356%
89
-18%
127
+43%
208
+63%
276
+33%
349
+26%
329
-6%
489
+48%
Shares Outstanding
Common Shares Outstanding
2
4
6
9
9
11
13
37
46
59
105
196
222
226
237
Preferred Shares Outstanding
3
8
0
0
0
0
0
0
0
0
0
0
0
0
0